ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
暂无分享,去创建一个
Xiangxi Wang | Youchun Wang | Yunlong Cao | Lei Wang | Xiaosu Chen | Weiliang Song | Zhongyang Shen | F. Jian | Can Yue | Fei Gao
[1] M. Ma,et al. Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection , 2022, The Lancet Infectious Diseases.
[2] J. Zahradník,et al. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants , 2022, bioRxiv.
[3] Xuping Xie,et al. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster , 2022, Nature Medicine.
[4] M. Kiso,et al. Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB , 2022, The Lancet Infectious Diseases.
[5] Peng Wang,et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution , 2022, bioRxiv.
[6] A. Walls,et al. Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains , 2022, bioRxiv.
[7] Fei Shao,et al. Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75 , 2022, bioRxiv.
[8] Fei Shao,et al. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents , 2022, bioRxiv.